• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006-2015 年,40 岁以下男性肌营养不良症死亡率的种族和民族差异。

Differences in Race and Ethnicity in Muscular Dystrophy Mortality Rates for Males under 40 Years of Age, 2006-2015.

机构信息

Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA.

Department of Preventive Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.

出版信息

Neuroepidemiology. 2018;50(3-4):201-206. doi: 10.1159/000488244. Epub 2018 Apr 26.

DOI:10.1159/000488244
PMID:29698937
Abstract

BACKGROUND/AIMS: Duchenne Muscular Dystrophy (DMD) has childhood onset, primarily affects males, and is usually fatal before the age of 40 years. Previous studies have indicated that this X-linked condition is more prevalent in whites than in blacks, but those were based on active surveillance, and limited to smaller populations and younger ages.

METHODS

US death data were used to calculate mortality rates by race and ethnicity, with MD as either the underlying or multiple cause of death (MCD). Poisson approximation was used for confidence intervals; chi-square was used to compare rates.

RESULTS

From 2006 to 2015, there were 3,256 deaths in males <40 years with MD as MCD, and 71% of these were aged 15-29 years. For whites, the average annual death rate was 0.43/100,000, which was significantly higher (p < 0.0001) that that of blacks (0.28), American Indian/Alaska Natives (0.20), and Asian/Pacific Islanders (0.21). The rate for non-Hispanic whites (0.46) was significantly higher (p < 0.0001) than the rates for Hispanic whites (0.31), Hispanic blacks (0.07), and non-Hispanic blacks (0.29).

CONCLUSION

Since DMD is the primary cause of deaths in young males with MD, mortality rates are a reasonable proxy for the relative difference in racial prevalence. It appears that DMD is significantly more common in white males than in males of other races.

摘要

背景/目的:杜氏肌营养不良症(DMD)发病于儿童期,主要影响男性,通常在 40 岁之前致命。先前的研究表明,这种 X 连锁疾病在白种人中比在黑种人中更为普遍,但这些研究是基于主动监测,且仅限于较小的人群和较年轻的年龄。

方法

使用美国死亡数据按种族和族裔计算死亡率,将肌营养不良症作为主要或多种死因(MCD)。使用泊松逼近法计算置信区间;使用卡方检验比较比率。

结果

2006 年至 2015 年,有 3256 名 40 岁以下男性死于肌营养不良症作为 MCD,其中 71%的年龄在 15-29 岁之间。对于白人,平均年死亡率为 0.43/100,000,明显高于黑人(0.28)、美洲印第安人/阿拉斯加原住民(0.20)和亚裔/太平洋岛民(0.21)。非西班牙裔白人的比率(0.46)明显高于西班牙裔白人(0.31)、西班牙裔黑人(0.07)和非西班牙裔黑人(0.29)。

结论

由于 DMD 是导致年轻男性肌营养不良症死亡的主要原因,因此死亡率是种族流行率相对差异的合理替代指标。看来 DMD 在白人男性中比在其他种族的男性中更为常见。

相似文献

1
Differences in Race and Ethnicity in Muscular Dystrophy Mortality Rates for Males under 40 Years of Age, 2006-2015.2006-2015 年,40 岁以下男性肌营养不良症死亡率的种族和民族差异。
Neuroepidemiology. 2018;50(3-4):201-206. doi: 10.1159/000488244. Epub 2018 Apr 26.
2
Duchenne and Becker Muscular Dystrophies' Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences.Duchenne 和 Becker 肌营养不良症在 MD STARnet 监测点的患病率:对种族和民族差异的考察。
Neuroepidemiology. 2021;55(1):47-55. doi: 10.1159/000512647. Epub 2021 Jan 21.
3
State-specific prevalence of selected health behaviors, by race and ethnicity--Behavioral Risk Factor Surveillance System, 1997.按种族和族裔划分的特定州选定健康行为的患病率——行为风险因素监测系统,1997年
MMWR CDC Surveill Summ. 2000 Mar 24;49(2):1-60.
4
Is Heart Disease or Cancer the Leading Cause of Death in United States Women?在美国女性中,心脏病还是癌症是主要死因?
Womens Health Issues. 2016 Nov-Dec;26(6):589-594. doi: 10.1016/j.whi.2016.08.002. Epub 2016 Oct 4.
5
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014.美国 2000 年至 2014 年按种族或族裔划分的成人脑胶质瘤发病率和生存率。
JAMA Oncol. 2018 Sep 1;4(9):1254-1262. doi: 10.1001/jamaoncol.2018.1789.
6
Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.美国外周 T 细胞淋巴瘤发病率和生存率的种族模式。
J Clin Oncol. 2016 Mar 20;34(9):963-71. doi: 10.1200/JCO.2015.63.5540.
7
US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks.美国按出生体重/胎龄划分的新生儿死亡率:1995 - 1997年白人、西班牙裔和黑人的死亡率
Pediatrics. 2003 Jan;111(1):e61-6. doi: 10.1542/peds.111.1.e61.
8
Changes in COVID-19-Associated Deaths During a Year Among Blacks and Hispanics Compared to Whites in the State of Connecticut.康涅狄格州黑人和西班牙裔与白人 COVID-19 相关死亡人数在一年内的变化比较。
J Racial Ethn Health Disparities. 2022 Oct;9(5):2049-2055. doi: 10.1007/s40615-021-01143-z. Epub 2021 Sep 28.
9
Trends and racial disparities in muscular dystrophy deaths in the United States, 1983-1998: an analysis of multiple cause mortality data.1983 - 1998年美国肌肉萎缩症死亡的趋势及种族差异:多死因死亡率数据的分析
Am J Med Genet A. 2006 Nov 1;140(21):2289-97. doi: 10.1002/ajmg.a.31437.
10
Prevalence of Duchenne and Becker muscular dystrophies in the United States.美国杜氏和贝克肌营养不良症的患病率。
Pediatrics. 2015 Mar;135(3):513-21. doi: 10.1542/peds.2014-2044. Epub 2015 Feb 16.

引用本文的文献

1
Biological Sex and the Association Between Grip Strength and Cardiovascular Disease: a Scoping Review.生物性别与握力和心血管疾病之间的关联:一项范围综述
Can Geriatr J. 2025 Jun 4;28(2):169-179. doi: 10.5770/cgj.28.814. eCollection 2025 Jun.
2
Real-world treatment and health care utilization among patients with Duchenne muscular dystrophy by race and ethnicity in a Medicaid population.医疗补助计划人群中,不同种族和族裔的杜氏肌营养不良患者的实际治疗及医疗保健利用情况。
J Manag Care Spec Pharm. 2025 Feb 1;31(2):205-213. doi: 10.18553/jmcp.2025.31.2.205.
3
Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network.
肌肉萎缩症监测、跟踪和研究网络中杜氏肌营养不良症患者的临床和人口统计学特征及全因死亡率的选择。
Neuromuscul Disord. 2022 Jun;32(6):468-476. doi: 10.1016/j.nmd.2022.04.008. Epub 2022 Apr 30.
4
Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity.特定疾病的健康差异:聚焦种族和族裔的针对性综述
Healthcare (Basel). 2022 Mar 23;10(4):603. doi: 10.3390/healthcare10040603.
5
A population-based study of mortality due to muscular dystrophies across a 36-year period in Spain.一项针对西班牙 36 年间肌肉萎缩症死亡率的基于人群的研究。
Sci Rep. 2022 Mar 8;12(1):3750. doi: 10.1038/s41598-022-07814-z.
6
Epidemiological Characteristics of Infectious Diseases Among Travelers Between China and Foreign Countries Before and During the Early Stage of the COVID-19 Pandemic.《新冠疫情大流行前及初期中国出入境旅行者传染病流行病学特征》。
Front Public Health. 2021 Nov 3;9:739828. doi: 10.3389/fpubh.2021.739828. eCollection 2021.
7
The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review.糖皮质激素治疗时代杜氏肌营养不良症的临床病程:系统文献回顾。
Orphanet J Rare Dis. 2021 May 22;16(1):237. doi: 10.1186/s13023-021-01862-w.
8
Handgrip strength and health outcomes: Umbrella review of systematic reviews with meta-analyses of observational studies.握力与健康结局:对观察性研究系统评价的荟萃分析进行伞式综述。
J Sport Health Sci. 2021 May;10(3):290-295. doi: 10.1016/j.jshs.2020.06.009. Epub 2020 Jun 19.
9
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.推动药物研发工具的监管认可,以促进模型指导的药物研发在杜氏肌营养不良症中的应用。
J Pharmacokinet Pharmacodyn. 2019 Oct;46(5):441-455. doi: 10.1007/s10928-019-09642-7. Epub 2019 May 24.
10
Urban-Rural Disparity in Cancer Incidence, Mortality, and Survivals in Shanghai, China, During 2002 and 2015.2002年至2015年期间中国上海城乡地区癌症发病率、死亡率及生存率的差异
Front Oncol. 2018 Dec 3;8:579. doi: 10.3389/fonc.2018.00579. eCollection 2018.